Hepatitis A vaccination in chronic carriers of hepatitis B virus.
Because hepatitis A infection may be more severe in patients with chronic liver disease, we vaccinated 33 children who were chronic HBsAg carriers against hepatitis A virus. Anti-hepatitis A virus seroconversion rates after the first, second, and third doses were 90.9%, 96.9%, and 100%, respectively.
Nebbia
G
G
First Pediatric Clinic and Institute of Virology, University of Milan, Milan, Italy; Department of Infectious diseases, G. Gaslini Children's Hospital of Genoa, Genoa, Italy.
Giacchino
R
R
Soncini
R
R
Ramaccioni
V
V
Timitilli
A
A
Zanetti
A R
AR
D000293:Adolescent; D002353:Carrier State; D002648:Child; D002675:Child, Preschool; D005260:Female; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control*; D022362:Hepatitis A Vaccines; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006515:Hepatitis B virus / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000276:immunology*; D006801:Humans; D008297:Male; D014611:Vaccination; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
D022362:Hepatitis A Vaccines; D006514:Hepatitis B Surface Antigens; D014761:Viral Hepatitis Vaccines